Functional Parameters of Physiological Systems of Laboratory Primates after Administration of Doxorubicin and Transplantation of Mesenchymal Stem Cells
- Авторы: Agrba V.1, Agrba V.1, Karal-ogly D.1, Kal’sina S.1, Konoplyannikov A.1, Gvozdik T.1, Gvaramiya I.1, Klots I.1, Mukhametzyanova E.1, Chuguev Y.1, Shamsutdinova O.1, Araviashvili D.1, Porkhanov V.1, Lapin B.1
-
Учреждения:
- Research Institute of Medical Primatology
- Выпуск: Том 165, № 1 (2018)
- Страницы: 115-120
- Раздел: Cell Technologies in Biology and Medicine
- URL: https://journals.rcsi.science/0007-4888/article/view/240039
- DOI: https://doi.org/10.1007/s10517-018-4111-0
- ID: 240039
Цитировать
Аннотация
We studied physiological parameters of rhesus monkeys after administration of anthracycline antibiotic doxorubicin. Intravenous administration of the drug caused intoxication manifested in in an abrupt body weight loss, baldness, vomiting, and exicosis. Intoxication in monkeys determined by the damaging effects of doxorubicin on organs and tissues is also characterized by significant changes in the blood: leukopenia, thrombocytopenia, neutropenia, monocytopenia, lymphocytosis, and a sharp drop of CD20+ B cell content. The total protein and albumin content in the blood significantly decreased. A sharp increase in C-reactive protein was also accompanied by an increase in activity of proinflammatory cytokine IL-6. Transplantation of mesenchymal stem cells in some cases can significantly alleviate doxorubicin-induced damage to organs and maintain normal clinical status of monkeys after two injections of the drug. Late transplantation of stem cells does not have a protective effect and does not protect the animals from the damaging effects of doxorubicin. We found that the protective effect of mesenchymal stem cells depends on the dose of the drug, total number of cells, and the time of their transplantation. It should be noted that human and monkey mesenchymal stem cells produce similar regenerative effects, at least in the doxorubicin toxicity model.
Об авторах
V. Agrba
Research Institute of Medical Primatology
Автор, ответственный за переписку.
Email: agrba-vz@mail.ru
Россия, Sochi
V. Agrba
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
D. Karal-ogly
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
S. Kal’sina
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
A. Konoplyannikov
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
T. Gvozdik
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
I. Gvaramiya
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
I. Klots
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
E. Mukhametzyanova
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
Yu. Chuguev
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
O. Shamsutdinova
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
D. Araviashvili
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
V. Porkhanov
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi
B. Lapin
Research Institute of Medical Primatology
Email: agrba-vz@mail.ru
Россия, Sochi